-
Kizdar net |
Kizdar net |
Кыздар Нет
Ozmosi | RTX-GRT7039 Drug Profile
Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually …
Study Details | NCT05248386 | Efficacy and Safety of RTX-GRT7039 …
Mar 18, 2026 · A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and …
Open-label Trial to Check the Safety an... | NCT05377489 | deltatrials
Feb 26, 2026 · Consult a healthcare provider before making any medical decision. A PHASE3 clinical study on Osteoarthritis, this …
Efficacy and Safety of RTX-GRT7039 in A... | NCT05248386 | deltatrials
Consult a healthcare provider before making any medical decision. This PHASE3 trial investigates Osteoarthritis and is currently …
RTX-GRT7039 Phase 3 — 103 sites, updated Mar 2026 | DataLookout
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated …
This pivotal trial is intended to be an integral part of the overall efficacy and safety assessment of RTX GRT7039 and will be used to …
RTX-GRT7039 - Clinical Trials Pipeline - FindTrial
Aug 26, 2022 · A single-arm, open-label, Phase III trial to evaluate the safety and tolerability of intra-articular injections of RTX …
RTX-GRT7039 Phase 3 — 81 sites, updated Mar 2026 | DataLookout
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of single …
Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 ...
May 11, 2022 · A Single-arm, Open-label, Phase III Trial to Evaluate the Safety and Tolerability of Intra-articular Injections of RTX …
Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 ...
Jul 14, 2026 · An open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular …
Skip to content
Accessibility Feedback